LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SEQUENTIAL TREATMENT OF BRAF MUTANT ADVANCED MELANOMA PATIENTS

被引：0
|
作者：
Tarhini, Ahmad [1 ]
McDermott, David [2 ,3 ]
Ambavane, Apoorva [4 ]
Benedict, Agnes [4 ]
Lee, Cho-Han [5 ]
Ritchings, Corey [5 ]
Stwalley, Brian [5 ]
Regan, Meredith [2 ,6 ]
Atkins, Michael [7 ]
机构：
[1] Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Evidera, London, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：A130 / A131
页数：2
相关论文
共 50 条
  • [1] Clinical and economic outcomes associated with sequential treatment in BRAF mutant advanced melanoma patients
    Tarhini, Ahmad A.
    McDermott, David F.
    Ambavane, Apoorva
    Gupte-Singh, Komal
    Ritchings, Corey
    Aponte-Ribero, Valerie
    Benedict, Agnes
    Rao, Sumati
    Regan, Meredith M.
    Atkins, Michael B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma
    Tarhini, Ahmad
    McDermott, David
    Ambavane, Apoorva
    Gupte-Singh, Komal
    Aponte-Ribero, Valerie
    Ritchings, Corey
    Benedict, Agnes
    Rao, Sumati
    Regan, Meredith M.
    Atkins, Michael
    [J]. IMMUNOTHERAPY, 2019, 11 (04) : 283 - 295
  • [3] Long-term outcomes in patients with BRAF-mutant advanced melanoma: A real-world study
    Amin, A.
    Pavlick, A. C.
    Lee, C.
    Chou, E.
    Zhang, Y.
    Sakkal, L. A.
    Moser, J.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1415 - S1416
  • [4] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [5] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    [J]. Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [6] Long-term outcomes of advanced BRAF-mutated melanoma patients and complete or partial response
    Chatziioannou, E.
    Sinnberg, T.
    Leiter-Stoeppke, U.
    Flatz, L.
    Amaral, T.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 75 - 76
  • [7] Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment
    Mak, Gabriel
    Arkenau, Hendrik-Tobias
    Chin, Melvin
    [J]. MELANOMA RESEARCH, 2014, 24 (04) : 408 - 412
  • [8] BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma
    Richman, Juliet
    Martin-Liberal, Juan
    Diem, Stefan
    Larkin, James
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (09) : 1285 - 1297
  • [9] Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma
    Goodman, Rachel S.
    Di Guardo, Lorenza
    Maurichi, Andrea
    Kirwin, Brendan
    Khattak, Adnan
    Vanella, Vito
    Lee, Joanna
    Lawless, Aleigha
    Czapla, Juliane
    Spagnoletti, Andrea
    Ambrosini, Margherita
    Livingstone, Elisabeth
    V. Long, Georgina
    Sullivan, Ryan J.
    Carlino, Matteo S.
    Atkinson, Victoria
    Trojanello, Claudia
    Ascierto, Paolo A.
    Schadendorf, Dirk
    Warburton, Lydia
    Menzies, Alexander M.
    Santinami, Mario
    Johnson, Douglas B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 194
  • [10] Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors
    Ismail, Rawa K.
    Suijkerbuijk, Karijn P. M.
    de Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne L.
    Pasmooij, A. M. G.
    van Zeijl, Michiel C. T.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Boers-Sonderen, Marye J.
    de Groot, Jan W. B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Piersma, Djura
    van Rijn, Rozemarijn S.
    van der Veldt, Astrid A. M.
    Vreugdenhil, Art
    Westgeest, Hans
    van den Eertwegh, Alfons J.
    Wouters, Michel W. J. M.
    [J]. MELANOMA RESEARCH, 2022, 32 (06) : 460 - 468
12345